2022
Overview
Dilated cardiomyopathy (DCM) is a disease of the heart muscle in which the heart's main pumping chambers, particularly the left ventricle, become enlarged and weakened, reducing the heart's ability to pump blood effectively. It is a leading cause of heart failure and can result from a range of causes, including genetic factors, prior viral infection, toxins, and other conditions, though in many cases the cause is not identified. As the weakened heart struggles to meet the body's circulatory demands, patients may develop symptoms of heart failure such as breathlessness, fatigue, and fluid retention, along with risks of arrhythmia and clot formation. Diagnosis typically relies on imaging such as echocardiography to assess chamber size and pumping function. Within the journal's cardiology scope, related research addresses the broader landscape of heart failure and cardiac disease, including work on cardiorenal signaling pathways in heart failure and comparisons of coronary artery disease patterns in patients presenting with acute coronary syndromes. Such studies illuminate the mechanisms and management of impaired cardiac function that overlap with the consequences of dilated cardiomyopathy. This page brings together peer-reviewed, open-access research relevant to dilated cardiomyopathy and the broader study of heart-muscle disease and heart failure.
Research published in this journal
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
2016
2021
How this research is being cited
The 3 articles above have been cited 1 time in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.
-
2016 · Journal of Hypertension and Cardiology
A sample of recent works citing this journal's research on Dilated Cardiomyopathy, linking to each citing work.